Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment
出版年份 2021 全文链接
标题
Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment
作者
关键词
-
出版物
Cell Death Discovery
Volume 7, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-18
DOI
10.1038/s41420-021-00401-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CXCR7 reactivates ERK signaling to promote resistance to EGFR kinase inhibitors in NSCLC.
- (2019) Jeffrey H Becker et al. CANCER RESEARCH
- Glutamine Deprivation Induces PD-L1 Expression via Activation of EGFR/ERK/c-Jun Signaling in Renal Cancer
- (2019) Guofeng Ma et al. MOLECULAR CANCER RESEARCH
- Enhanced glycolysis supports cell survival in EGFR-mutant lung adenocarcinoma by inhibiting autophagy-mediated EGFR degradation
- (2018) Ji Hye Kim et al. CANCER RESEARCH
- NRF2 facilitates breast cancer cell growth via HIF1ɑ-mediated metabolic reprogramming
- (2018) Hong-Sheng Zhang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer
- (2016) Nan Zhang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Modulation of Macrophage Inflammatory Nuclear Factor κB (NF-κB) Signaling by IntracellularCryptococcus neoformans
- (2016) James B. Hayes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Systematic investigation of metabolic reprogramming in different cancers based on tissue-specific metabolic models
- (2016) Fangzhou Shen et al. Journal of Bioinformatics and Computational Biology
- Cancer statistics for Hispanics/Latinos, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor- B to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
- (2015) J. Peng et al. CANCER RESEARCH
- Classifying Cancers Based on T-cell Infiltration and PD-L1
- (2015) Michele W.L. Teng et al. CANCER RESEARCH
- PD-L1 expression as a potential predictive biomarker
- (2015) Alberto Fusi et al. LANCET ONCOLOGY
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- Is PD-L1 Expression a Biomarker of Response?
- (2015) Cancer Discovery
- HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients
- (2013) S. Munir et al. CANCER RESEARCH
- Increase in claudin-2 expression by an EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cells
- (2012) Akira Ikari et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
- (2012) X. Jiang et al. CLINICAL CANCER RESEARCH
- PD-1/PD-L1 Interactions Contribute to Functional T-Cell Impairment in Patients Who Relapse with Cancer After Allogeneic Stem Cell Transplantation
- (2011) W. J. Norde et al. CANCER RESEARCH
- Lactate: A Metabolic Key Player in Cancer
- (2011) F. Hirschhaeuser et al. CANCER RESEARCH
- Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action
- (2010) Yongtao Jiang et al. CYTOTECHNOLOGY
- Hypoxic Tumor Microenvironment and Cancer Cell Differentiation
- (2009) Yuri Kim et al. CURRENT MOLECULAR MEDICINE
- Mechanisms of tumor resistance to EGFR-targeted therapies
- (2009) Elizabeth A Hopper-Borge et al. EXPERT OPINION ON THERAPEUTIC TARGETS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started